Clinical Trials Logo
  1. Home
  2. Other
  3. NCT03042078

Zero-fluoroscopy Approach Versus Fluoroscopic Approach for the Ablation of Paroxysmal Supraventricular Tachycardia — ZFA-PSVT  

Paroxysmal Supraventricular Tachycardia Clinical Trial

Official title:
Multi-center, Controlled Trial to Compare the Feasibility, Safety and Efficacy of Zero-fluoroscopic Approach With Fluoroscopic Approach for the Ablation of Paroxysmal Supraventricular Tachycardia

Clinical Trial Summary

This study is aimed to compare the feasibility, safety and efficacy of a zero-fluoroscopic approach using Ensite NavX with conventional fluoroscopic approach using Ensite NavX plus fluoroscopy for the ablation of paroxysmal supraventricular tachycardia.

Clinical Trial Description

Fluoroscopy is the imagine modality routinely used in catheter ablation of cardiac arrhythmias. As we all know,fluoroscopic radiation is harmful both to the patients and the operation staffs. Recently,three-dimensional navigation systems have been developed and implemented in electrophysiological procedures for guiding catheters inside the heart chambers. Among the three-dimensional navigation systems, Ensite NavX is a promising system used for zero-fluoroscopic approach for performing catheter ablation of paroxysmal supraventricular tachycardia. This study is aimed to compare the feasibility, safety and efficacy of a zero-fluoroscopic approach using Ensite NavX with conventional fluoroscopic approach using Ensite NavX plus fluoroscopy for the ablation of paroxysmal supraventricular tachycardia. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT03042078
Study type Interventional
Source Tongji Hospital
Contact
Status Completed
Phase N/A
Start date January 2012
Completion date December 2018
View Details
See also
  Status Clinical Trial Phase
Completed NCT04072835 - Safety Study of Etripamil Nasal Spray for Patients With Paroxysmal Supraventricular Tachycardia. NODE-303 Phase 3
Completed NCT01655316 - Oral Verapamil in Acute Paroxysmal Supra Ventricular Tachycardia(PSVT) Recurrence Control Phase 4
Completed NCT05770921 - Pulsed Field Ablation for Paroxysmal Supraventricular Tachycardia（PSVT） N/A
Active, not recruiting NCT05820035 - A Multicenter Study of Pulsed Field Ablation for Paroxysmal Supraventricular Tachycardia N/A
Not yet recruiting NCT06327425 - MCG for Localization of Tachyarrhythmia's Origin N/A
Recruiting NCT05410860 - Efficacy and Safety Study of Etripamil Nasal Spray Self-Administration for the Termination of Spontaneous Episodes of Paroxysmal Supraventricular Tachycardia Phase 3
Completed NCT03464019 - Efficacy and Safety of Etripamil for the Termination of Spontaneous Paroxymal Supraventricular Tachycardia (PSVT). NODE 301 [Part 1 and Part 2 (RAPID Study)] Phase 3
Completed NCT04215640 - Radiofrequency Ablation of Paroxysmal Supraventricular Tachycardia Using a Novel Catheter Equipped With Mini Electrodes N/A
Completed NCT03348436 - Study on Left Atrial Function of Paroxysmal Supraventricular Tachycardia After Radiofrequency Ablation N/A
Enrolling by invitation NCT04952610 - Etripamil Nasal Spray in Patients With Paroxysmal Supraventricular Tachycardia Phase 3
Recruiting NCT05763953 - The NODE-202 Study (Study of Etripamil Nasal Spray in Pediatric Patients) Phase 2
Terminated NCT03635996 - Safety Study of Intranasal Etripamil for the Termination of Spontaneous Episodes of Paroxysmal Supraventricular Tachycardia (PSVT). NODE-302 Phase 3